Each obuprazine dose group demonstrated statistically significant and clinically meaningful improvements versus placebo on ...

The double-blind, randomised study evaluated 363 adult patients across 24 clinical centres in China.

Tortugas Neuroscience’s schizophrenia drug from Hansoh Pharma has proven its worth in a phase 2b study, validating the ...

A herb encyclopedia that fuses sophisticated 'adult learning' with 'vibrant sensibility'.In this 18th installment, we unravel ...

Detailed price information for Aytu Biopharma Inc (AYTU-Q) from The Globe and Mail including charting and trades.

Three “dopamine stabilizers” share a label but not a risk profile. Here's where the akathisia, ICD, and indication data actually diverge.

A second on-label option carries its own distinct mechanism and its own trial history. The panel details how this ...

Detailed price information for Aytu Biopharma Inc (AYTU-Q) from The Globe and Mail including charting and trades.

A new scientific review concludes that acidic cannabinoids including THCA, CBDA and CBGA are pharmacologically active compounds with potential therapeutic relevance across a range of … Continue readin ...

A new mouse study shows that a complex between the sigma-1 receptor and the serotonin 1A receptor disinhibits a key serotonin ...

Recently published Schizophrenia Market Insights report includes a comprehensive understanding of current treatment practices, emerging schizophrenia drugs, market share of individual therapies, and ...

Lumateperone and pimavanserin both skip D2 blockade for 5-HT2A activity, but only one expanded to three indications. Here's what to know before prescribing either.